GEORDIE Shore star Aaron Chalmers’ terrified ex has described the “scariest week of her life” after their son was hospitalised.
Talia says it’s a “long road to recovery” as she praised Oakley who has been battling sepsis.
The worried mum has been sleeping by his hospital bedside after he underwent multiple operations.
Oakley, who was born with the rare genetic disorder Apert Syndrome, was rushed to surgery to drain the serious infection from his head.
Sharing pictures from hospital, Talia wrote on Instagram: “The scariest week of my life. Three surgeries in a week, when only one was planned.
“Fluid resuscitation, incubated, lumbar drain, external drain in the head, three large CSF fluid leaks, two infections one of them being sepsis. Oakley my boy you are a true warrior.
“You make me appreciate life so much. I couldn’t be any prouder.
“I no you still have a long road to recovery but you are amazing.
“I have so much appreciation for other medical families and what they have to go through.
“The medical staff have been unbelievable.”
Aaron, and Talia, 32, share three children together which include Romeo, four, Maddox, three and one year-old Oakley.
The pair previously split up in December 2022 after five years together following a series of rows.
APERT syndrome, also known as acrocephalosyndactyly, is a rare disorder that is named after the doctor who first discovered it in the early 20th century.
It is a genetic condition and is caused by a mutation of the FGFR2 gene.
This affects how cells in the body – namely bone cells – grow, divide and die.
Children born with Apert syndrome have a characteristic appearance, which is caused by the bones in the skull and face fusing and not growing in proportion, according to Great Ormond Street Hospital.
It can increase a child’s risk of hydrocephalus, which results in pressure building on the brain, and it can also cause Chiari malformation, where the base of the brain is squeezed.
Other complications include breathing difficulties and heart problems, which require life-long monitoring.
The condition is said to occurs in one in every 65,000 to 88,000 births and a child’s outlook can vary greatly depending on the severity of symptoms.
